Good medicine, bad medicine

Written by Howard Lovy
Published May 08, 2004

Robert Bradbury has some good news and some bad news about the National Institutes of Health nanomedicine roadmap initiative shindig this week:

    The good news... The NIH really seems to understand that to make progress in nanotech one must integrate researchers from various areas of expertise. The bad news... Few if any people attending the conference have read any of the background literature on what nanotechnology or nanomedicine really involve. When I mentioned or or , during the interactive periods they generally were unrecognized. This seems to be consistent with the Drexler v. Smalley debate which suggests that most scientists simply have not done their homework (in terms of learning about nanotechnology). More here

Related Posts
Nanobots: Body and antibody
Do no harm: Don't forget Freitas
For greener planet, remove people; results may vary

Keep reading for information and comments on this article, and add some feedback of your own!
Good medicine, bad medicine
Published: May 08, 2004
Type:
Section: Culture
Writer: Howard Lovy
Howard Lovy's BC Writer page
Howard Lovy's personal site
Spread the Word
Like this article?
Email this
Submit to del.icio.us Save to del.icio.us
RSS Feeds
All RSS Feeds (240+)
Comments on this article
BC articles by Howard Lovy
All Culture Articles
All BC articles
All BC Comments

Comments

Want comments emailed to you? No spam, promise! Address:

Add your comment, speak your mind

(Or ping: http://blogcritics.org/mt/tb/15482)

Personal attacks are not allowed. Please read our comment policy.





Remember Name/URL?

Please preview your comment!

Fresh
Articles
Fresh
Comments